Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


ENDRA Life Sciences Signs Vietnam Distribution Agreement For TAEUS


Benzinga | Dec 7, 2020 09:13AM EST

ENDRA Life Sciences Signs Vietnam Distribution Agreement For TAEUS

Exclusive agreement for Vietnam includes the sale of at least 40 liver imaging systems

ANN ARBOR, MI / ACCESSWIRE / December 7, 2020 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a developer of enhanced ultrasound technologies, today announced that Quang Phat Technology Science Equipment Co. Ltd, signed an exclusive distribution agreement for the sale of ENDRA's Thermo Acoustic Enhanced UltraSound (TAEUS) liver systems in Vietnam. The agreement requires the purchase of more than 40 units over the three-year term in order to maintain exclusivity. Sales are expected to begin as soon as TAEUS receives U.S. Food and Drug Administration (FDA) clearance and local regulatory approvals.

While ENDRA is currently focused on commercialization efforts in Europe, where TAEUS already received the CE regulatory mark, the Company has selectively pursued global market expansion with other partners via its participation at international tradeshows and conferences.

This distribution agreement represents ENDRA's first in Southeast Asia with a partner who wanted to secure early, exclusive rights to sell TAEUS in a country where NAFLD has been growing significantly.

"Our pivot to digital marketing that was necessitated by the COVID-19 pandemic, as well as our strong historical presence at global clinical conferences since 2018 have allowed ENDRA to highlight the features and benefits of our groundbreaking technology in assessing NAFLD and NASH to a global audience. This has led to our first commercial agreement with a strong marketing partner in Vietnam," said Renaud Maloberti, ENDRA's Chief Commercial Officer.

"Vietnam's population of 96 million with a high prevalence of liver disease presents a significant opportunity for TAEUS to cost-effectively address a growing need for the early and non-invasive detection of liver disease. We are proud to be partnered with such an innovative company as ENDRA," said Tien Bang, Director of Quang Phat Technology






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC